Embryotox is a renowned brand and a trusted source of information for the safety of medication during pregnancy and breastfeeding. As a pharmacovigilance and consultation center for embryotoxicology at Charité-Universitätsmedizin Berlin, we have been providing independent information since 1988. Our website, launched in October 2008, offers a comprehensive database on over 400 drugs.

While our information is based on the latest scientific data, it may not always correspond with the details provided in package inserts, patient information leaflets, or the Red List (Off-label use). In addition to medication compatibility, we also offer guidance on various common conditions and their treatment during pregnancy. If you require personalized advice, our team is available to assist you, and our consultation service is free of charge.

By documenting and analyzing pregnancy outcomes, we strive to improve knowledge about the safety and risks associated with medication use during pregnancy. Your participation, especially if you are pregnant, will contribute to enhancing the quality and safety of our website. Healthcare professionals can rely on our information to facilitate decision-making, but it's important to consult with a healthcare provider before making any changes to your treatment plan.

Embryotox is supported by public funding and operates under the Pharmakovigilanzauftrag issued by the Federal Institute for Drugs and Medical Devices (BfArM)